| scholarly article | Q13442814 |
| P356 | DOI | 10.1155/2011/385780 |
| P8608 | Fatcat ID | release_nvq3dmbfsbbb5ectrr3zzftpkm |
| P932 | PMC publication ID | 3134205 |
| P698 | PubMed publication ID | 21765617 |
| P5875 | ResearchGate publication ID | 51498849 |
| P50 | author | Bruce P Burnett | Q88571070 |
| Lakshmi Pillai-Kastoori | Q59270697 | ||
| Alessandra Bitto | Q85352180 | ||
| Domenica Altavilla | Q85352184 | ||
| Francesco Squadrito | Q87638204 | ||
| P2093 | author name string | Robert M Levy | |
| P2860 | cites work | High levels of fat and (n-6) fatty acids in cancellous bone in osteoarthritis | Q24800912 |
| Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 | ||
| Cyclooxygenase enzymes: regulation and function | Q28167256 | ||
| Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases | Q28364861 | ||
| The protecting effects and mechanisms of Baicalin and Octreotide on heart injury in rats with SAP | Q28577045 | ||
| The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay | Q29616616 | ||
| Leukotrienes and lipoxins: structures, biosynthesis, and biological effects | Q29617543 | ||
| Antioxidant activity applying an improved ABTS radical cation decolorization assay | Q33865975 | ||
| Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. | Q34138303 | ||
| Green tea catechins inhibit pancreatic phospholipase A(2) and intestinal absorption of lipids in ovariectomized rats. | Q50729647 | ||
| Association between metabolic factors and knee osteoarthritis in women: the Chingford Study | Q51588077 | ||
| Substitution of tyrosine for the proximal histidine ligand to the heme of prostaglandin endoperoxide synthase 2: implications for the mechanism of cyclooxygenase activation and catalysis. | Q52579266 | ||
| Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis. | Q53141426 | ||
| Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. | Q54570365 | ||
| Nitric-Oxide Mediates Suppression of Cartilage Proteoglycan Synthesis by Interleukin-1 | Q59141927 | ||
| Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo-arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects | Q62618716 | ||
| Concerted loss of cyclooxygenase and peroxidase activities from prostaglandin H synthase upon proteolytic attack | Q69233083 | ||
| Leukotriene synthesis by human gastrointestinal tissues | Q70147548 | ||
| Higher oxidation states of prostaglandin H synthase. Rapid electronic spectroscopy detected two spectral intermediates during the peroxidase reaction with prostaglandin G2 | Q70373614 | ||
| Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase | Q70442855 | ||
| Nitric oxide activates metalloprotease enzymes in articular cartilage | Q71667841 | ||
| Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage | Q72687835 | ||
| Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE | Q72992381 | ||
| Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin | Q73150982 | ||
| Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer? | Q74426661 | ||
| Oxidant and anti-oxidant systems of synovial fluid from patients with knee post-traumatic arthritis | Q79822878 | ||
| Inflammation in osteoarthritis | Q80062501 | ||
| Enhanced gastric mucosal leukotriene B4 synthesis in patients taking non-steroidal anti-inflammatory drugs | Q34376929 | ||
| Flavocoxid, a dual inhibitor of cyclooxygenase‐2 and 5‐lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis | Q34388999 | ||
| Inflammatory mediators in gastrointestinal defense and injury | Q34462954 | ||
| The role of reactive oxygen species in homeostasis and degradation of cartilage | Q34537354 | ||
| Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. | Q35132201 | ||
| Metabolic mechanisms in the pathogenesis of osteoarthritis. A review. | Q36558603 | ||
| Structural and functional basis of cyclooxygenase inhibition | Q36752887 | ||
| PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants--a new role as anti-inflammatory molecule. | Q36800479 | ||
| Clinical effects of Garcinia kola in knee osteoarthritis | Q36855408 | ||
| Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action | Q37137703 | ||
| Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages | Q37395300 | ||
| Arachidonic acid cascade and signal transduction | Q37815882 | ||
| Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk | Q39313069 | ||
| A medicinal plant extract of Scutellaria Baicalensis and Acacia catechu reduced LPS-stimulated gene expression in immune cells: a comprehensive genomic study using QPCR, ELISA, and microarray | Q39661850 | ||
| A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation | Q40077624 | ||
| Prostaglandins, Arachidonic Acid, and Inflammation | Q40122354 | ||
| Oxidants as stimulators of signal transduction | Q41260199 | ||
| The generation and actions of isoprostanes. | Q41433804 | ||
| Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons. | Q41659967 | ||
| Leukotrienes: lipid bioeffectors of inflammatory reactions | Q41731446 | ||
| Differential modification of cyclo-oxygenase and peroxidase activities of prostaglandin endoperoxidase synthase by proteolytic digestion and hydroperoxides | Q42050957 | ||
| Inhibition of neutrophil phospholipase A2 by p-bromophenylacyl bromide, nordihydroguaiaretic acid, 5,8,11,14-eicosatetraynoic acid and quercetin. | Q42227295 | ||
| Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee- a subset analysis | Q42849028 | ||
| Cost analysis of flavocoxid compared to naproxen for management of mild to moderate OA. | Q42944276 | ||
| Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies | Q43015771 | ||
| GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin | Q43131558 | ||
| Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone. | Q43270173 | ||
| Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats | Q43290345 | ||
| DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants | Q43772116 | ||
| Novel fluorometric assay for hydroxyl radical prevention capacity using fluorescein as the probe. | Q43975123 | ||
| Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. | Q44588871 | ||
| Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide | Q45122003 | ||
| Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. | Q45952848 | ||
| Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis. | Q46413279 | ||
| Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity | Q46967735 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 385780 | |
| P577 | publication date | 2011-06-19 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant | |
| P478 | volume | 2011 |
| Q48220372 | A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury |
| Q43928450 | Bioguidage search of active compounds from Waltheria indica L. (Malvaceae) used for asthma and inflammation treatment in Burkina Faso |
| Q26750933 | Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review |
| Q48194110 | Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice |
| Q36252843 | Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia. |
| Q41052689 | Flavocoxid attenuates gentamicin-induced nephrotoxicity in rats. |
| Q41919479 | Flavocoxid exerts a potent antiviral effect against hepatitis B virus. |
| Q41952624 | Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis |
| Q38253044 | Flavocoxid, a nutraceutical approach to blunt inflammatory conditions. |
| Q38545133 | Medical Plant Extracts for Treating Knee Osteoarthritis: a Snapshot of Recent Clinical Trials and Their Biological Background |
| Q35108710 | Modulation of basophils' degranulation and allergy-related enzymes by monomeric and dimeric naphthoquinones. |
| Q38558587 | Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety |
| Q38450512 | Proinflammatory Pathways: The Modulation by Flavonoids. |
Search more.